Frankfurt - Delayed Quote EUR

AIM ImmunoTech Inc. (HXB2.F)

0.0610
0.0000
(0.00%)
At close: April 4 at 3:50:39 PM GMT+2
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
170
170
202
141
135
Cost of Revenue
31
31
42
0
850
Gross Profit
139
139
160
141
-715
Operating Expense
19,911
19,911
32,076
20,064
16,344
Operating Income
-19,772
-19,772
-31,916
-19,923
-17,059
Net Non Operating Interest Income Expense
4,607
4,607
1,069
629
-67
Other Income Expense
-2,155
-2,155
1,885
-151
-2,001
Pretax Income
-17,320
-17,320
-28,962
-19,445
-19,127
Net Income Common Stockholders
-17,320
-17,320
-28,962
-19,445
-19,127
Diluted NI Available to Com Stockholders
-17,320
-17,320
-28,962
-19,445
-19,127
Basic EPS
-0.31
--
-0.60
-0.40
-0.40
Diluted EPS
-0.31
--
-0.60
-0.40
-0.40
Basic Average Shares
56,016.8700
--
48,585.4040
48,047.2880
47,339.9750
Diluted Average Shares
56,016.8700
--
48,585.4040
48,047.2880
47,339.9750
Total Operating Income as Reported
-19,772
-19,772
-31,916
-19,923
-18,838
Total Expenses
19,942
19,942
32,118
20,064
17,194
Net Income from Continuing & Discontinued Operation
-17,320
-17,320
-28,962
-19,445
-19,127
Normalized Income
-16,769
-16,769
-29,180
-17,804
-14,807
Interest Income
5,192
5,192
1,069
629
0
Interest Expense
585
585
0
0
67
Net Interest Income
4,607
4,607
1,069
629
-67
EBIT
-16,735
-16,735
-28,962
-19,923
-19,060
EBITDA
-16,489
-16,489
-28,724
-19,667
-18,285
Reconciled Cost of Revenue
31
31
42
0
850
Reconciled Depreciation
246
246
238
256
775
Net Income from Continuing Operation Net Minority Interest
-17,320
-17,320
-28,962
-19,445
-19,127
Total Unusual Items Excluding Goodwill
-551
-551
218
-1,641
-4,320
Total Unusual Items
-551
-551
218
-1,641
-4,320
Normalized EBITDA
-15,938
-15,938
-28,942
-18,026
-13,965
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 1/3/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ACHV Achieve Life Sciences, Inc.
3.0800
+12.82%
 
HEPA Hepion Pharmaceuticals, Inc.
0.3180
0.00%
 
OTLK Outlook Therapeutics, Inc.
1.7500
+4.48%
 
ATOS Atossa Therapeutics, Inc.
0.9701
-1.57%